Inventor

Michael Hale

Inventor
Bedford, MA, US

Overview

46→
Patents
2001–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
C07CAcyclic or carbocyclic compounds8%
C07HSugars3%
LOC232%
PatentTitleYear
RE048266Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto2020RE047318Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates thereto2019RE046097'Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto'20168,455,497'Inhibitors of aspartyl protease'20137,919,523'Inhibitors of aspartyl protease'20117,592,368'Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors'20097,501,415'Selective inhibitors of ERK protein kinase and uses thereof'20097,462,612'Pyridine inhibitors of ERK2 and uses thereof'20087,456,190'Compositions useful as protein kinase inhibitors'20087,442,718'Inhibitors of aspartyl protease'20087,419,967'Sulfonamide inhibitors of aspartyl protease'20087,407,962'Heteroaryl compounds useful as inhibitors or protein kinases'20087,358,258'Prodrugs of an ERK protein kinase inhibitor'20087,354,939'Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto'20087,354,919'Isoxazole compositions useful as inhibitors of ERK'20087,345,054'Heterocyclic inhibitors of ERK2 and uses thereof'20087,304,071'Protein kinase inhibitors and uses thereof'20077,304,061'Heterocyclic inhibitors of ERK2 and uses thereof'20077,279,476'Pyrazole-derived kinase inhibitors and uses thereof'20077,253,187'Heterocyclic inhibitors of ERK2 and uses thereof'20077,244,735'Heterocyclic protein kinase inhibitors and uses thereof'20077,183,307'Pyrazole-derived kinase inhibitors and uses thereof'20077,169,798'Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases'20077,056,944'Pyrazole compositions useful as inhibitors of erk'20066,962,936'Triazole-derived kinase inhibitors and uses thereof'20056,949,580'Pyrazole compositions useful as inhibitors of ERK'2005D0505193'Evaporative cooler'20056,878,728'Inhibitors of aspartyl protease'20056,875,789'Pyrazole-derived kinase inhibitors and uses thereof'2005D0503222'Evaporative cooler'20056,838,474'Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors'20056,784,195'Pyrazole compositions useful as inhibitors of ERK'20046,750,239'Pyrazole-derived kinase inhibitors and uses thereof'20046,743,791'Heterocyclic inhibitors of ERK2 and uses thereof'20046,706,711'Pyrazole derived kinase inhibitor'20046,699,865'Pyrazole compositions useful as inhibitors of ERK'20046,693,108'Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases'20046,649,640'Isoxazole compositions useful as inhibitors of ERK'20036,617,350'Inhibitors of aspartyl protease'20036,613,743'Sulfonamide inhibitors of aspartyl protease'20036,593,357'Pyrazole compositions useful as inhibitors of ERK'20036,559,137'Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors'20036,528,509'Pyrazole compositions useful as inhibitors of ERK'20036,495,582'Isoxazole compositions useful as inhibitors of ERK'20026,436,989'Prodrugs of aspartyl protease inhibitors'20026,319,946'Inhibitors of aspartyl protease'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2020Patents assigned to VERTEX PHARMA (42)· patent assignee history
2001–2020Based in Bedford, MA, US· patent location history
2005Based in Indianapolis, IN, US· patent location history
2013Patents assigned to BRIEGER MICHAEL STEPHEN (1)· patent assignee history
2013Patents assigned to FURFINE ERIC STEVEN (1)· patent assignee history
2013Patents assigned to HALE MICHAEL R (1)· patent assignee history
2013Patents assigned to JARVIS ASHLEY NICHOLAS (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA422001–2020
BRIEGER MICHAEL STEPHEN12013
FURFINE ERIC STEVEN12013
HALE MICHAEL Rself12013
JARVIS ASHLEY NICHOLAS12013
Locations
LocationPatentsSpan
Bedford, Massachusetts, US442001–2020
Indianapolis, IN, US22005